Rock Springs Capital Management LP Uni Qure N.V. Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $6.1 Million - $8.76 Million	-208,500 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $7.24 Million - $10.4 Million	-204,933 Reduced 49.57%	208,500 $7.53 Million
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $226,673 - $300,258	6,300 Added 1.55%	413,433 $15.2 Million
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $321,412 - $483,189	7,133 Added 1.78%	407,133 $18.3 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $7.63 Million - $15.3 Million	205,500 Added 105.66%	400,000 $28.7 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $7.66 Million - $14.9 Million	194,500 New	194,500 $7.66 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.